• Panel Detects Demyelinating Neuropathy Biomarkers: John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S.

  • 2024/09/17
  • 再生時間： 14 分
  • ポッドキャスト

Panel Detects Demyelinating Neuropathy Biomarkers: John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S.

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S., explain how Mayo Clinic Laboratories' new test panel can distinguish among various potential causes of demyelinating neuropathies. Test results are important for managing these devastating autoimmune conditions.

    Show notes

    Speaker 3: (00:32)
    Would you provide a little background on yourself, Dr. Mills?

    Speaker 3: (01:19)
    Dr. Dubey?

    Speaker 3: (02:07)
    Can you give a brief overview of our demyelinating test and recommended use?

    Speaker 3: (03:52)
    Can you discuss how this new test will assist in a patient's journey?

    Speaker 3: (05:46)
    Can you tell us some of the unique features of this test?

    Speaker 3: (08:09)
    Dr. Dubey, as a neurologist, how does this test set us apart in the market?

    Speaker 3: (11:05)
    Could you summarize the benefits of having both a demyelinating panel and an axonal panel?

    Speaker 3: (11:40)
    Why should a patient have an axonal or demyelinating test versus a sensory and motor test for peripheral neuropathy?
    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S., explain how Mayo Clinic Laboratories' new test panel can distinguish among various potential causes of demyelinating neuropathies. Test results are important for managing these devastating autoimmune conditions.

Show notes

Speaker 3: (00:32)
Would you provide a little background on yourself, Dr. Mills?

Speaker 3: (01:19)
Dr. Dubey?

Speaker 3: (02:07)
Can you give a brief overview of our demyelinating test and recommended use?

Speaker 3: (03:52)
Can you discuss how this new test will assist in a patient's journey?

Speaker 3: (05:46)
Can you tell us some of the unique features of this test?

Speaker 3: (08:09)
Dr. Dubey, as a neurologist, how does this test set us apart in the market?

Speaker 3: (11:05)
Could you summarize the benefits of having both a demyelinating panel and an axonal panel?

Speaker 3: (11:40)
Why should a patient have an axonal or demyelinating test versus a sensory and motor test for peripheral neuropathy?
身体的病い・疾患 衛生・健康的な生活 科学
続きを読む 一部表示

Panel Detects Demyelinating Neuropathy Biomarkers: John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S.に寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。